Transcriptomics

Dataset Information

26

Expression data from Caenorhabditis elegans exposed to albendazole


ABSTRACT: We have investigated how the model nematode Caenorhabditis elegans responds to and metabolizes albendazole; an important anthelmintic for human and animal parasite control. The transcriptional response of the mutant strain CB3474 ben-1(e1880)III, which is highly resistant to benzimidazoles due to a null mutation in the β-tubulin drug target, was examined. This approach was successful in minimizing transcriptional responses associated with non-specific stress or with the drug mode of action, resulting in only in a small subset of genes showing differential expression in response to drug exposure. Overall design: Matched cultures of synchronised C. elegans were grown to young adult stage in liquid culture. The nematodes were then exposed to 300 µg/ml albendazole (ABZ) or exposed only to the DMSO excipient used to deliver the albendazole (CONT) for 4 hours. RNA was extracted from three biological replicates and hybridised to Affymetrix arrays.

INSTRUMENT(S): [Celegans] Affymetrix C. elegans Genome Array

ORGANISM(S): Caenorhabditis elegans  

SUBMITTER: Steven Thomas Laing  

PROVIDER: GSE21747 | GEO | 2010-06-14

SECONDARY ACCESSION(S): PRJNA127333

REPOSITORIES: GEO

Similar Datasets

2010-06-23 | E-GEOD-21747 | ArrayExpress
2011-04-01 | GSE22660 | GEO
2011-04-01 | E-GEOD-22660 | ArrayExpress
| GSE101645 | GEO
| GSE101680 | GEO
2017-10-01 | E-MTAB-5705 | ArrayExpress
| PRJNA395200 | ENA
| GSE16975 | GEO
2007-12-01 | GSE8058 | GEO
2013-07-30 | E-GEOD-16975 | ArrayExpress